ISPE Gathers Global Aseptic Leaders to Discuss Trends and Innovations
Now in its 29th year, this signature event has established itself as the pharmaceutical industry's leading source on advancing aseptic and barrier operations and providing invaluable opportunities for peer-to-peer learning through interactions with industry and regulatory leaders.
BETHESDA, Md., Jan. 16, 2020 /PRNewswire-PRWeb/ -- The International Society for Pharmaceutical Engineering (ISPE) announced its 2020 ISPE Aseptic Conference, taking place 2–3 March 2020 in North Bethesda, Maryland. Now in its 29th year, this signature event has established itself as the pharmaceutical industry's leading source on advancing aseptic and barrier operations and providing invaluable opportunities for peer-to-peer learning through interactions with industry and regulatory leaders.
"While many conferences just discuss the theoretical aspects of aseptic, barrier, and containment, the ISPE Aseptic Conference provides attendees with insights from owner experiences and lessons learned through in-depth presentations, panel discussions, and group breakout sessions," said Jörg Zimmermann, 2020 ISPE Aseptic Conference Chair, Vice President Vetter Development Service, External Affairs, Vetter Pharma-Fertigung GmbH & Co KG. "The education agenda will address the most pressing industry concerns and interests, including robotics, ATMPs, and automated visual inspections."
The 2020 program will focus on providing flexible and reliable solutions for the implementation and management of the latest in aseptic, barrier, containment, and aseptic best-practice technologies.
Featured speakers include:
Richard Friedman, Deputy Director, Science and Regulatory Policy, FDA/CDER
- Robert Sausville, Director, Div. Case Management, FDA/CBER
- David Doleski, Compliance Head for Biologics Quality Operations, Sanofi
- Christophe Riedel, CEO, Claranor SA
- Eugen Goidenko, Executive Vice President, Bausch Advanced Technologies Inc.
- Dawn Watson, Director, Microbial Control & Sterile Site Support Sterile & Validation COE, Merck & Co., Inc.
- Zhihao Qiu, PhD, Director (Acting), Office of Pharmaceutical Manufacturing Assessment, FDA/CDER/OPQ/OPF
- Brooke Higgins, Senior Policy Advisor, Office of Manufacturing Quality, Division of Drug Quality, FDA/CDER/OC/OMQ
- And more
To explore the agenda and to register, please visit ISPE.org/Aseptic20.
About ISPE
The International Society for Pharmaceutical Engineering (ISPE) is the world's largest not-for-profit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The 18,500 members of ISPE are building solutions in the development and manufacture of safe, effective pharmaceutical and biologic medicines, and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters and training center in North Bethesda, Maryland USA, and its operations center in Tampa, Florida USA. Visit ISPE.org for more information.
For more information, contact:
Amy Henry
Marketing Communications Manager
International Society for Pharmaceutical Engineering (ISPE)
Tel: +1-813-960-2105
Email: [email protected]
ISPE.org
SOURCE ISPE
Share this article